Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1988]

In vitro diagnostic models for ALL: what can we learn on actionable targets?

Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland

In vitro diagnostic models for ALL: what can we learn on actionable targets? ( Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland )

For HSCT in Ph-positive ALL

Prof Oliver Ottmann - Cardiff University, Cardiff, UK

For HSCT in Ph-positive ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )

Bispecific T-cell engaging therapy for adult ALL

Prof Max Topp - University of Würzburg, Würzburg, Germany

Bispecific T-cell engaging therapy for adult ALL ( Prof Max Topp - University of Würzburg, Würzburg, Germany )

Optimal use of TKIs for therapy of Ph-positive ALL

Dr Josep Ribera - Catalan Institute of Oncology, Badalona, Spain

Optimal use of TKIs for therapy of Ph-positive ALL ( Dr Josep Ribera - Catalan Institute of Oncology, Badalona, Spain )

Management of relapsed T-ALL in children

Prof Josef Vormoor - Newcastle University, Newcastle, UK

Management of relapsed T-ALL in children ( Prof Josef Vormoor - Newcastle University, Newcastle, UK )

Combining MRD quantitation and genetics in post-remission risk stratification

Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK

Combining MRD quantitation and genetics in post-remission risk stratification ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )

Transplanting adult ALL patients

Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology...

Transplanting adult ALL patients ( Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland )

Management of MLL-rearranged ALL

Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht...

Management of MLL-rearranged ALL ( Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands )

Against HSCT in Ph-positive ALL

Prof Robin Foa - Professor of Haematology and Head of Haematology, University...

Against HSCT in Ph-positive ALL ( Prof Robin Foa - Professor of Haematology and Head of Haematology, University of Rome, Rome, Italy )

CAR-T cells: challenges and opportunities

Dr Sara Ghorashian - University College London, London, UK

CAR-T cells: challenges and opportunities ( Dr Sara Ghorashian - University College London, London, UK )

Update on targeted therapies for Philadelphia-like ALL

Prof Stephen Hunger - Children’s Hospital of Philadelphia, Philadelphia, USA

Update on targeted therapies for Philadelphia-like ALL ( Prof Stephen Hunger - Children’s Hospital of Philadelphia, Philadelphia, USA )

Large B-cell lymphoma: ZUMA-1 trial

Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA

Large B-cell lymphoma: ZUMA-1 trial ( Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA )

More from ecancer